MOBERG DERMA RECRUITS SALES & MARKETING DIRECTOR
The Swedish pharmaceutical company Moberg Derma today announces that it is strengthening its organization through the recruitment of Martin Ingman as Sales & Marketing Director.
Martin Ingman will be responsible for building Moberg Derma’s international network of distributors as well as the company’s sales organisation for the Nordic markets. Martin brings 15 years of experience within sales and marketing. His latest position was as Marketing Director at Carema and previously he held leading commercial positions at Q-Med and Astra.
Moberg Derma is developing several dermatological pharmaceuticals based on the company’s patented Kaprolac® principle. The company prepares the launch of its first two products, a solution and a shampoo against seborrheic dermatitis and dandruff, during the second half of 2009. Recently positive results were reported from a clinical phase III study for K101 against nail fungus. Further, a clinical phase II study for K201 against atopic dermatitis will be initiated in January 2009.
Contact:
Peter Wolpert, President and CEO
Telephone: +46 8 522 307 00
Mobile: +46 70 735 71 35
E-mail: peter.wolpert@mobergderma.se
For further information, please visit our website: www.mobergderma.se
About Moberg Derma
Moberg Derma AB is a Swedish pharmaceutical company that develops and commercializes patented dermatological pharmaceuticals to treat common skin diseases. The company focuses on innovative products based on proven compounds and has product candidates in advanced phases of clinical development. Moberg Derma intends to market pharmaceuticals in the Nordic region and outlicense product rights to partners and distributors in other markets. The company began operations at the Karolinska Institute in 2006 and currently has 11 employees. The principal owners are Östersjösstiftelsen (the Baltic Sea Foundation), private investors and corporate management.
Tags: